【24h】

Risk-benefit analysis of pulmonary CT angiography in patients with suspected pulmonary embolus

机译:疑似肺栓塞患者的肺部CT血管造影风险获益分析

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE. The objective of our study was to estimate the mortality benefit-to-risk ratio of pulmonary CT angiography (CTA) by setting (ambulatory [emergency department or outpatient] or inpatient), age, and sex. MATERIALS AND METHODS. A retrospective evaluation of 1424 consecutive pulmonary CTA examinations was performed and the following information was recorded: examination setting, patient age, patient sex, pulmonary CTA interpretation for pulmonary embolus (PE), and CT radiation exposure (dose-length product). We estimated mortality benefit of pulmonary CTA by multiplying the rate of positive pulmonary CTA examinations by published estimates of mortality of untreated PE in ambulatory and inpatient settings. We estimated the lifetime attributable risk of cancer mortality due to radiation from pulmonary CTA by calculating the estimated effective dose and using sex-specific polynomial equations derived from the Biological Effects of Ionizing Radiation VII report. We calculated benefit-torisk ratios by dividing the mortality benefit of preventing a fatal PE by the mortality risk of a radiation-induced cancer. RESULTS. Pulmonary CTA diagnosed PE in 188 of 1424 patients (13.2%). Both inpatients (101/723, 14.0%) and emergency department patients (74/509, 14.5%) had significantly higher rates of PE than outpatients (13/192 [6.8%]). Males received significantly (p = 0.02451) higher radiation dose (9.7 mSv) than females (8.4 mSv), but males had a significantly (p < 0.0001) lower lifetime attributable risk of cancer mortality than females. Assuming an untreated PE mortality rate of 5% for ambulatory patients and 30% for inpatients, the benefitto- risk ratio ranged from 25 for ambulatory patients to 187 for inpatients. Ambulatory women had the lowest benefit-to-risk ratio. CONCLUSION. The benefit-to-risk ratio of pulmonary CTA in patients with suspected PE ranges from 25 to 187 and can be increased by optimizing the radiation dose.
机译:目的。我们研究的目的是通过设置(非流动性[紧急部门或门诊病人]或住院病人),年龄和性别来估计肺部CT血管造影术(CTA)的死亡率效益比。材料和方法。回顾性评估了1424个连续的肺CTA检查,并记录了以下信息:检查设置,患者年龄,患者性别,肺CTA对肺栓塞(PE)的解释以及CT辐射暴露(剂量长度乘积)。我们通过将肺部CTA阳性检查率乘以已发表的门诊和住院环境中未经治疗的PE的死亡率估算值来估算肺部CTA的死亡率收益。我们通过计算估计的有效剂量并使用从电离辐射VII生物效应报告中得出的性别特异性多项式方程式,估算了因肺部CTA辐射而导致的癌症死亡的终生归因风险。我们通过将预防致命PE的死亡率收益除以辐射诱发癌症的死亡率风险来计算收益率比。结果。肺部CTA在1424例患者中的188例中诊断为PE(13.2%)。住院患者(101 / 723,14.0%)和急诊患者(74 / 509,14.5%)的PE率均显着高于门诊患者(13/192 [6.8%])。男性的辐射剂量(9.7 mSv)明显高于女性(8.4 mSv)(p = 0.02451),但男性的终生归因于癌症的风险要比女性低(p <0.0001)。假设门诊患者未经治疗的PE死亡率为5%,住院患者为30%,则受益风险比范围为门诊患者为25,住院患者为187。非卧床妇女的受益风险比最低。结论。疑似PE患者的肺部CTA获益比为25至187,可以通过优化放射剂量来提高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号